The therapeutic potential of bee venom-derived Apamin and Melittin conjugates in cancer treatment: A systematic review

Pharmacol Res. 2024 Nov:209:107430. doi: 10.1016/j.phrs.2024.107430. Epub 2024 Sep 26.

Abstract

The therapeutic potential of bee venom-derived peptides, particularly apamin and melittin, in cancer treatment has garnered significant attention as a promising avenue for advancing oncology. This systematic review examines preclinical studies highlighting the emerging role of these peptides in enhancing cancer therapies. Melittin and apamin, when conjugated with other therapeutic agents or formulated into novel delivery systems, have demonstrated improved efficacy in targeting tumor cells. Key findings indicate that melittin-based conjugates, such as polyethylene glycol (PEG)ylated versions, show potential in enhancing therapeutic outcomes and minimizing toxicity across various cancer models. Similarly, apamin-conjugated formulations have improved the efficacy of established anti-cancer drugs, contributing to enhanced targeting and reduced systemic toxicity. These developments underscore a growing interest in leveraging bee venom-derived peptides as adjuncts in cancer therapy. The integration of these peptides into treatment regimens offers a promising strategy to address current limitations in cancer treatment, such as drug resistance and off-target effects. However, comprehensive validation through clinical trials is essential to confirm their safety and effectiveness in human patients. This review highlights the global emergence of bee venom-derived peptides in cancer treatment, advocating for continued research and development to fully realize their therapeutic potential.

Keywords: Apamin; Bee venom; Cancer therapy; Conjugates; Cytotoxicity; Melittin; Nanoformulations; Preclinical studies.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Apamin* / chemistry
  • Apamin* / pharmacology
  • Apamin* / therapeutic use
  • Bee Venoms* / chemistry
  • Bee Venoms* / therapeutic use
  • Humans
  • Melitten* / chemistry
  • Melitten* / pharmacology
  • Melitten* / therapeutic use
  • Neoplasms* / drug therapy

Substances

  • Melitten
  • Bee Venoms
  • Antineoplastic Agents
  • Apamin